Page values for "Apolizumab"
Jump to navigation
Jump to search
"_pageData" values
1 row is stored for this page| Field | Field type | Value |
|---|---|---|
| _pageID | Integer | 853,696 |
| _pageName | Page | Apolizumab |
| _pageTitle | String | Apolizumab |
| _pageNamespace | Integer | 0 |
"definitions" values
1 row is stored for this page| Field | Field type | Value |
|---|---|---|
| Term | Page | Apolizumab |
| Short_definition | String | Apolizumab (a-puh-LIZ-yoo-mab) A substance being studied for the treatment of haematological (blood) cancer. Apolizumab attaches to a protein called ID10, which is found on the surface of some types of immune cells and cancer cells. |
| Type | Page | Cancer terms |
| Specialty | Page | Oncology |
| Language | Page | English |
| Source | Page | NCI |
| Comments | String |